Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotype
Journal of Experimental Medicine · 2026
DOI: 10.1084/jem.20250194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Tayla B Heavican-Foral und 27 weiteren Autor:innen. Beteiligte Einrichtung: Pathology, Microbiology, and Immunology, University of Nebraska Medical Center , Omaha, NE, USA. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Proto-Oncogene Proteins, Lymphoma, T-Cell, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: NCI NIH HHS, Leukemia and Lymphoma Society, NIH HHS.
Abstract (Originalsprache)
TET2 mutations are frequent in TFH-derived lymphomas, but how epigenetic disruption initiates malignant T cell transformation is unclear. We generated Cd4cre;Tet2FL/FL mice, which developed aggressive T cell lymphoma (m-TCL) with a TFH cell–like immunophenotype. Genome-wide transcriptomics and epigenetic profiling of Tet2−/− CD4+ T cells prior to lymphoma development showed hyperactive TCR, PI3K signaling, and dysregulated TH differentiation program, with proliferation promoting signal transduction at the lymphoma stage. Tet2 loss promoted hyperplasticity under in vitro conditions but favored conditional TFH differentiation. Reduced 5-hmC levels at regulatory genomic elements, resulted in transcriptional rewiring of TFH-associated genes, promoting ICOS(L)-mediated PI3K signaling. TET2-KO human CD4+ T cells showed conserved epigenetic changes with increased proliferation, decreased exhaustion, increased memory marker expression, and clonal expansion with restricted TCR repertoire under in vitro conditions. scRNA-seq revealed a persistent proliferative cluster characterized by elevated stem-like transcriptional features compared with WT counterparts. Tet2−/− m-TCLs allografted into NSG mice showed a significant response to epigenetic (5-azacytidine) and PI3K inhibitors (duvelisib) alone or in combination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pathology, Microbiology, and Immunology, University of Nebraska Medical Center , Omaha, NE, USA.
- Medical Oncology, Dana-Farber Cancer Institute , Boston, MA, USA.
- Department of Pathology, City of Hope National Medical Center, Duarte, CA, USA.
- Department of Pathology and Laboratory Medicine, Miller School of Medicine, University of Miami, Coral Gables, FL, USA.
- College of Arts and Science, University of Nebraska at Omaha , Omaha, NE, USA.
- Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
ORCID-Profile: Tayla B Heavican-Foral, Yuping Li, Waseem Lone, Alyssa Bouska, Jibin Zhang, Ruimeng Yang, Xuxiang Liu, Ab Rauf Shah, Abdul Rouf Mir, Joseph Rohr, Dylan Jochum, Anurag Kumar, Ravneet Singh Chawla, Catalina Amador, Tyler Herek, Jacob Robinson, Chengfeng Bi, Sunandini Sharma, Tyler Gilbreath, R Katherine Hyde, Timothy W McKeithan, Chan-Wang Lio, Anjana Rao, Giorgio Inghirami, Joesph Khoury, Wing C Chan, Javeed Iqbal
Förderung
- NCI NIH HHS
- Leukemia and Lymphoma Society
- NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Heavican-Foral, T. B., Li, Y., Lone, W., Bouska, A., Zhang, J., Yang, R., Liu, X., Shah, A. R., Mir, A. R., Rohr, J., Jochum, D., Kumar, A., Chawla, R. S., Amador, C., Yu, J., Herek, T., Robinson, J., Bi, C., Sharma, S., …, & Iqbal, J. (2026). Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotype. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20250194
Vancouver
Heavican-Foral TB, Li Y, Lone W, Bouska A, Zhang J, Yang R, et al. Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotype. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20250194
BibTeX
@article{HeavicanForal2026,
author = {Heavican-Foral, Tayla B and Li, Yuping and Lone, Waseem and Bouska, Alyssa and Zhang, Jibin and Yang, Ruimeng and Liu, Xuxiang and Shah, Ab Rauf and Mir, Abdul Rouf and Rohr, Joseph and Jochum, Dylan and Kumar, Anurag and Chawla, Ravneet Singh and Amador, Catalina and Yu, Jiayu and Herek, Tyler and Robinson, Jacob and Bi, Chengfeng and Sharma, Sunandini and Gilbreath, Tyler and Hyde, R Katherine and McKeithan, Timothy W and Lio, Chan-Wang and Rao, Anjana and Inghirami, Giorgio and Khoury, Joesph and Chan, Wing C and Iqbal, Javeed},
title = {Tet2 deficiency alters CD4+ T cell function and promotes T cell lymphoma with a TFH cell immunophenotype},
journal = {Journal of Experimental Medicine},
year = {2026},
doi = {10.1084/jem.20250194}
}
EUVIMED